Table 3 Correlations of clinicopathological characteristics and FOXP1 expression with the overall survival in patients with ICC
Group | Case number(n) | Overall survival (moth) | Mann–Whitney U | p |
|---|---|---|---|---|
Age (years) | ||||
 ≥ 63 | 28 | 12(2–95) | 532 | 0.727 |
 < 63 | 40 | 13(2–96) |  |  |
Sex | ||||
 Male | 33 | 14(2–95) | 534 | 0.589 |
 Female | 35 | 18(2–96) |  |  |
Differentiation | ||||
 Moderately-well | 45 | 13(2–96) | 514 | 0.522 |
 Poorly | 23 | 12(2–95) |  |  |
Hepatitis | ||||
 Yes | 10 | 11(2–30) | 238 | 0.362 |
 No | 58 | 15(2–96) |  |  |
Tumor size (cm) | ||||
 < 5 | 19 | 15(3–96) | 444 | 0.768 |
 ≥ 5 | 49 | 14(2–95) |  |  |
Lymph node metastasis | ||||
 Yes | 27 | 10(2–77) | 359 | 0.015 |
 No | 41 | 18(2–96) |  |  |
Invasion | ||||
 YES | 19 | 11(2–37) | 260 | 0.005 |
 No | 49 | 20(2–96) |  |  |
TNM Stages | ||||
 I-II | 38 | 21(2–96) | 312 | 0.001 |
 III | 30 | 11.(2–40) |  |  |
Star lesion | ||||
 Yes | 26 | 12(2–58) | 437 | 0.168 |
 No | 42 | 16(2–96) |  |  |
Micronerve infiltration | ||||
 Yes | 12 | 13(2–80) | 375 | 0.729 |
 No | 56 | 14(2–96) |  |  |
Vessel invasion | ||||
 Yes | 10 | 11(2–34) | 253 | 0.521 |
 No | 58 | 14(2–96) |  |  |
FOXP1 | ||||
 +  | 37 | 18(2–96) | 373 | 0.013 |
 - | 31 | 9(2–77) |  |  |